NCT02134184View on ClinicalTrials.gov

The Influence of Chronic CMV Infection on Influenza Vaccine Responses

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Cytomegalovirus InfectionsInfluenza
Interventions
BIOLOGICAL

Fluzone® 2012-2013 Formula NDC No 498281-012-50

This vaccine is given intramuscularly

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT02134184 - The Influence of Chronic CMV Infection on Influenza Vaccine Responses | Biotech Hunter | Biotech Hunter